74
Views
0
CrossRef citations to date
0
Altmetric
Review

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension

, , , , &
Pages 45-57 | Published online: 24 Dec 2018

References

  • Aguilar-OlivosNMotola-KubaMCandiaRHemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: systematic review and meta-analysisAnn Hepatol201413442042824927613
  • CarbonellNPauwelsASerfatyLFourdanOLévyVGPouponRImproved survival after variceal bleeding in patients with cirrhosis over the past two decadesHepatology200440365265915349904
  • Garcia-TsaoGBoschJManagement of varices and variceal hemorrhage in cirrhosisN Engl J Med2010362982383220200386
  • D’AmicoGGarcia-TsaoGPagliaroLNatural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studiesJ Hepatol200644121723116298014
  • LiTKeWSunPCarvedilol for portal hypertension in cirrhosis: systematic review with meta-analysisBMJ Open201665e010902
  • LiLYuCLiYEndoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysisCan J Gastroenterol201125314715521499579
  • SarinSKVallaDCde FranchisRRevising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJ Hepatol201154510821083
  • SinagraEPerriconeGD’AmicoMTinèFD’AmicoGSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisAliment Pharmacol Ther201439655756824461301
  • SukKTHepatic venous pressure gradient: clinical use in chronic liver diseaseClin Mol Hepatol201420161424757653
  • KimTYLeeJGSohnJHHepatic venous pressure gradient predicts long-term mortality in patients with decompensated cirrhosisYonsei Med J201657113814526632394
  • TripathiDFergusonJWKocharNRandomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedHepatology200950382583319610055
  • CopaciIMicuLMindrutEVoiculescuM660 Endoscopic variceal ligation alone versus endoscopic variceal ligation plus carvedilol in variceal bleeding prophylaxis in cirrhotic patientsJ Hepatol2012562S261S262
  • MahmodAEssaSAbdel AalEDawodHEmanAEvaluation of carvedilol in prevention of first attack of variceal hemorrhage in patients with liver cirrhosisAfro-Egypt J Infect Endem Dis2012228791
  • LeitheadJAFergusonJWTripathiDImplications of long-term carvedilol administration for portal hypertension-related renal dysfunction: follow-up from a randomised controlled trialHepatology201358855A
  • StanleyAJDicksonSHayesPCMulticentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleedingJ Hepatol20146151014101924953021
  • ShahHAAzamZRaufJCarvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trialJ Hepatol201460475776424291366
  • KumarPKumarRSaxenaKNSecondary prophylaxis of variceal hemorrhage: a comparative study of band ligation, carvedilol and propranolol plus isosorbide mononitrateIndian J Gastroenterol201534A54
  • ZhongMZhangBXmLSignificance of NSBB in preventing earlier rehaemorrhagia after endoscopic ligation of the patients with esophageal varicesPract Pharm Clin Remed2016191113116
  • KhanMSMajeedAGhauriFComparison of carvedilol and esophageal variceal band ligation for prevention of variceal bleed among cirrhotic patientsAge (Years)20175214.7154.0754.54
  • Abd ElrahimAYFouadRKhairyMEfficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleedingHepatol Int2018121758229185106
  • MoherDShamseerLClarkeMPreferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statementSyst Rev201541125554246
  • HigginsJPTGreenSCochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009] The Cochrane Collaboration2009 Available from: http://www.cochrane-handbook.org, 2010Accessed December 10, 2018
  • Garcia-TsaoGAbraldesJGBerzigottiABoschJPortal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseasesHepatology201765131033527786365
  • BerzigottiAReigMAbraldesJGBoschJBruixJPortal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysisHepatology201561252653625212123
  • ThalheimerUBellisLPuotiCBurroughsAKShould we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? NoEur J Intern Med20112215721238884
  • Silva-JuniorGBaigesATuronFThe prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the techniqueHepatology20156251584159226238376
  • HwangJHShergillAKAcostaRDThe role of endoscopy in the management of variceal hemorrhageGastrointest Endosc201480222122725034836
  • La MuraVNicoliniATosettiGPrimignaniMCirrhosis and portal hypertension: the importance of risk stratification, the role of hepatic venous pressure gradient measurementWorld J Hepatol20157468825866605
  • VillanuevaCGrauperaIAracilCA randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosisHepatology20176551693170728100019
  • GluudLLKlingenbergSNikolovaDGluudCBanding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trialsAm J Gastroenterol2007102122842284818042114
  • ThieleMKragARohdeUGluudLLMeta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varicesAliment Pharmacol Ther201235101155116522449261
  • LoGHChenWCLinCKImproved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleedingHepatology200848258058718666235
  • KroegerRJGroszmannRJIncreased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive modelHepatology198551971012857150
  • ZipprichAGarcia-TsaoGRogowskiSFleigWESeufferleinTDollingerMMPrognostic indicators of survival in patients with compensated and decompensated cirrhosisLiver Int20123291407141422679906
  • BossenLKragAVilstrupHWatsonHJepsenPNonselective β-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three randomized controlled trials with 1198 patientsHepatology20166361968197626599983
  • RosselloXPocockSJJulianDGLong-term use of cardiovascular drugs: challenges for research and for patient careJ Am Coll Cardiol201566111273128526361160
  • AngeliPBernardiMVillanuevaCEASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJ Hepatol201869240646029653741